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Background/aims: To assess longitudinal 5-year results of cataract surgery on low vision 
patients.
Methods: In this prospective, long-time, observational case-series, we report the outcome regard-
ing the subjective visual function (n = 35) assessed by a visual function questionnaire (VF-14) 
and the visual acuity (n = 30) of surviving low vision patients 5 years after surgery. We compare 
with data recorded on the same patients before surgery and 4 months postoperatively.
Results: Five years after surgery, 57% had unchanged or better VF-14 score compared with 
preoperatively, and 37% compared with postoperatively. Maculopathy patients had a signiﬁ  -
cantly larger deterioration 5 years after surgery compared with postoperatively (40.2 versus 
51.7, p = 0.004), but for the glaucoma patients there was no signiﬁ  cant change (52.6 versus 
53.1). There were no signiﬁ  cant associations between age of the patient and change in VF-14 
score or change in visual acuity 5 years after surgery, neither compared with before surgery 
nor postoperatively.
Conclusion: Results suggest a favorable functional outcome 5 years after cataract surgery on 
most low-vision patients. Glaucoma patients have a more stable outcome than patients with 
macular degeneration. The severity of the disease-process for each individual patient might be 
the most important factor affecting the long-time results.
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Introduction
Cataract is known to be the most common secondary diagnosis in low vision patients 
and has been estimated to be a concurrent cause in 75% of visually impaired people 
aged 70+ (Laatikainen and Hirvelä 1995; Elliott et al 1997).
Previous studies have shown that a large proportion of low vision patients with 
signiﬁ  cant cataract beneﬁ  t from cataract extraction (Mönestam and Wachtmeister 
1997; Lundström et al 2002; Armbrecht et al 2003).
Even though most low vision patients are old with a limited life span, it is important 
from a public health perspective to assess long-time results as low vision is responsible 
for a high proportion of social service needs, contributes to the loss of independence in 
older age, and increases mortality (Wang et al 1999, 2001; Buch et al 2001). Impaired 
vision has a large psychological impact on peoples’ lives, and it is important to establish 
the long-time results of cataract surgery to improve the counseling of patients with 
cataract and concurrent eye diseases (Carabellese et al 1993; Williams et al 1998).
The purpose of the study was to determine the longitudinal results of cataract 
surgery on the self-estimated ability to perform speciﬁ  c visual tasks and the relation 
to visual acuity in low vision patients.
Patients and methods
This prospective study included all patients attending the Low Vision Clinic, at Norrlands 
University Hospital in Umeå, Sweden, who were scheduled for cataract surgery Clinical Ophthalmology 2008:2(1) 188
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between June 1st 1997 and May 31st 1998. Patients who 
underwent cataract surgery, ie, small-incision phacoemulsiﬁ  -
cation, during the same time-period and were admitted to the 
Low Vision Clinic after surgery were also included (20/81; 
25%). These patients were found to have a non-treatable 
ocular disease, ﬁ  lling the criteria of low vision. In our area a 
functionally disabling cataract of the fellow eye is extracted 
before the patient is admitted to the Low Vision Clinic (LV). 
These patients were slightly but not signiﬁ  cantly younger 
than those who were already in The LV clinic. There was no 
signiﬁ  cant difference in diagnosis (except that no new patient 
had retinitis pigmentosa [RP]) and there was no signiﬁ  cant 
gender difference. All patients who had low vision before 
cataract surgery still had low vision after surgery. Prescribed 
low vision aids are free in Sweden, for that reason all patients 
attended the LV clinic postoperatively.
Low vision was deﬁ  ned in consistence with World Health 
Organization (WHO) criteria, as a binocular visual acuity 
of 0.3 (20/66) or worse if the peripheral visual ﬁ  elds were 
normal. If advanced losses of the visual ﬁ  elds were present, 
a visual acuity less than 0.5 (20/40) in the better eye was 
allowed (WHO 2001). Advanced visual ﬁ  eld losses were 
deﬁ  ned as a remaining binocular visual ﬁ  eld of less area than 
one normal visual ﬁ  eld.
Eighty-one low vision patients were enrolled in 1997–98. 
Five years later 39 had deceased (48%), 6 could not partici-
pate because of dementia (7%), and 1 patient (1%) could 
not be located. Thirty-ﬁ  ve patients participated with the 
questionnaire, ie, 97% of the eligible sample (35/36). In 
addition to the questionnaire, 30 patients also underwent 
an eye examination, 71% of the survivors (30/42). The 
major reason for not participating with the eye examination 
was trouble/unwillingness to travel to the eye clinic, either 
because of illness or long distance.
All patients were part of a larger population-based pro-
spective study of cataract surgery outcome described in detail 
in earlier publications (Mönestam et al 2005; Lundqvist and 
Mönestam 2006). The study followed the tenets of the decla-
ration of Helsinki. The Medical Ethics Committee of Umeå 
University, Sweden, approved this study, and all patients 
gave informed consent.
Pre- and postoperative data
The following data were recorded; age, sex, ﬁ  rst or second 
eye surgery, presenting and best corrected monocular visual 
acuity (BCVA), refraction of both eyes before surgery 
and postoperatively, type of surgery, complications, and 
diagnosis of the ocular comorbidity. No serious peri- or 
postoperative complications were noted. Only BCVA data 
are reported, as presenting visual acuity postoperatively and 
5 years after surgery were very similar.
Before surgery the patients answered a questionnaire 
regarding their subjective assessment of visual function 
and ability to perform visually demanding tasks (VF-14) 
(Steinberg et al 1994a, 1994b; Cassard et al 1995). All 
subjects were given the same instructions and were asked 
to answer the questionnaire using both eyes open and 
any habitually used spectacles and/or low vision aids. If 
the patient was unable to read the questionnaire, it was 
administered in a standardized manner by interview, or 
over the telephone for those patients unable to visit the 
clinic (n = 5).
Approximately 4–5 months postoperatively it was 
checked that glasses and necessary low-vision aids had been 
prescribed and trained. A third questionnaire similar to the 
ﬁ  rst and second was administered to the patients.
Five years after surgery it was checked which patients 
were still alive. All survivors were asked to participate 
with the same questionnaire, and a new eye examination. 
The examination was performed in the same manner as in 
1997–98.
Deﬁ  nitions of diagnoses
Only one diagnosis was chosen as the primary cause of low 
vision, as it was in most cases one disorder. When multiple 
disorders were present, the disease with the most clinically 
signiﬁ  cant and irreversible inﬂ  uence was chosen as the 
primary cause.
Each subject was assigned to a primary diagnostic 
category: (1): The maculopathy patients (M-patients), 
(n = 55/81; 68%). The macular function was depressed and 
the peripheral visual ﬁ  elds were normal. Age-related macular 
degeneration (ARM) (49/81; 60%), diabetic maculopathy 
(2/81; 2%), myopic maculopathy (4/81; 5%). Five years 
after surgery the M-group consisted of 22 patients, 20 with 
ARM, 1 with diabetic maculopathy, and 1 with myopic 
maculopathy. (2): The glaucoma patients (G-patients), 
(n = 23/81; 28%). These patients had advanced visual ﬁ  eld 
defects caused by glaucoma in 22 cases, and tumor of the 
hypophysis in 1 case. The visual ﬁ  eld losses were together 
larger than the size of one normal visual ﬁ  eld. Five years 
after surgery, 11 patients remained, 10 with glaucoma and 
1 with tumor-related extensive visual ﬁ  eld defects. (3): The 
retinitis pigmentosa patients (RP-patients) (n = 3/81; 4%). 
Five years after surgery, 2 patients remained and both had 
signs of maculopathy.Clinical Ophthalmology 2008:2(1) 189
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Statistical methods
Patients with failure to read any letters on the ETDRS-chart 
were tested using hand movements (HM), and light perception 
(P), and scored as outlined in earlier publications (Mönestam 
and Wachtmeister 1999; Mönestam and Lundqvist 2006). 
Change of VA was calculated as logMAR acuity (logVA) 
before surgery subtracted by logVA postoperatively or logVA 
postoperatively subtracted by logVA 5 years after surgery, 
respectively. For example: VA postoperatively = logMAR 0.8 
(Snellen 20/125) and VA 5 years after surgery = logMAR 1 
(Snellen 20/200), results in a deterioration of 0.8–1 = −0.2 
logMAR units.
Two-tailed t-tests were used to assess differences in age 
and VF-14 score. Mann-Whitney U-tests were used to com-
pare changes of VA postoperatively and 5 years after surgery. 
The two by two frequency tables were analyzed using Yates’ 
corrected chi-square tests or Fischers’ exact tests.
To calculate correlations Spearman’s rank correlation (rS) 
corrected for ties was used. Partial correlations statistics (rP) 
were performed to explore the correlations between the 5 year 
VA-results, VF-14 score, type of diagnosis, age, and gender.
The reading ability score was calculated by adding the 
scores of the 3 questions concerning subjective reading abil-
ity from the VF-14 questionnaire, ie, difﬁ  culties to read small 
print, newsprint and headlines, theoretical response-range 
0–12, with 0 meaning no ability to read, not even large print as 
headlines, and 12 meaning no perceived difﬁ  culties with read-
ing also small print) (Steinberg et al 1994a). Wilcoxon signed 
ranks tests were used to analyze the reading ability score.
The data were analyzed using the SSPS software 12.0 
(SPSS for Windows; SPSS, Chicago IL).
Results
Demographic characteristics, VA, 
and VF-14 score.
The demographic characteristics, VA-distribution, and sub-
jective visual function (VF-14 total score), before surgery, 
postoperatively, and 5 years after surgery of the 3 patient 
groups, are shown in Table 1.
The RP-patients were signiﬁ  cantly younger than the 
M- and G-patients (p  0.000) The results of the RP-patients 
are shown in Table 1, but no further statistical calculations 
have been made because of the small size of this patient group 
(n = 2–3). Postoperatively there was a highly signiﬁ  cant 
improvement of the VF-14 and the VA of the operated eye, 
as well as for the better-seeing eye for M- and G-patients 
(Table 1).
Five years after surgery there was a statistically signiﬁ  cant 
decrease in VA of the operated eye in both M- and G- patients 
(p = 0.026 and 0.003, respectively, Table 1). Regarding the 
VA of the better-seeing eye there was no signiﬁ  cant change. 
Most patients had had surgery on their fellow eyes during the 
5-year period (78%). Three patients had undergone YAG laser 
capsulotomy before the 5-year examination. No additional 
patient had posterior capsular opaciﬁ  cation at the time of the 
examination of such degree that YAG-laser was indicated.
The M-group had a signiﬁ  cantly worse VF-14 score 
5 years after surgery compared with postoperatively (40.2 
versus 51.7, p = 0.004). The VF-14 score of the G-group did 
not change signiﬁ  cantly (52.6 versus 53.1, Table 1).
Longitudinal change in VA and VF-14 score.
The change in VA, 5 years after surgery, regarding the oper-
ated eye and the better-seeing eye was generally scattered, 
with some patients having an excellent outcome with little 
loss, and others having a large deterioration (Table 2).
There were no signiﬁ  cant partial correlations in 5-year 
VA results in relation to age, gender and diagnosis of the 
patient. The associations between age and change in VA 
of the operated eye and better-seeing eye were rS = −0.20 
(p = 0.29) and rS = −0.04 (p = 0.84), respectively.
In Table 3 the distribution of change in VF-14 score, 
5 years after surgery versus before surgery, is shown. This 
analysis focus on the change in visual function 5 years 
after surgery, taking account of the surgical procedure, and 
also any second eye surgery during the follow up period. 
Fifty-seven percent (20/35) of the total patient group had 
an improved or better VF-14 score 5 years later, compared 
with before surgery.
The VF-14 score 5 years after surgery was also compared 
with the VF-14 score postoperatively, and 37% (13/35) of 
the patients were unchanged or better (Table 3). There were 
no statistically signiﬁ  cant associations between age of the 
patient and change in VF-14 score 5 years after surgery either 
compared with VF-14 before surgery or postoperatively 
(data not shown).
Reading ability
The median subjective reading ability score before surgery, 
postoperatively, and 5 years after surgery for the patient groups 
are shown in Table 4. Five years after surgery, 8 patients 
(8/35; 23%) had improved their reading score, 10 (10/35; 
29%) were unchanged and 17 (17/35; 49%) had worse reading 
score, compared with postoperatively almost 5 years earlier. 
The two RP-patients had had overall good subjective reading Clinical Ophthalmology 2008:2(1) 190
Mönestam et al
Table 1 Mean age, age-range, percentage of males, percentage of ﬁ  rst eye surgery,   VA-distribution, and subjective visual function 
(VF-14 total score), before surgery, postoperatively and 5 years after surgery
Diagnosis
All patients M-patients G-patients RP-patients p-value*
No of patients                          81 55 23 3
Mean age at surgery (years)             80.1 81.5 81.0 47.3 0.8
Range (years)     30–96 62–96 43–93 30–74
Males (%)   31 31 35 0 0.94
Surgery on ﬁ  rst eye (%) 72 69 77 67 0.59
VA operated eye before surgery 
                           20/90 or better
                           20/200–20/100
                           CF-20/250
                           P – HM
3
10
54
14
0
8
41
6
2
2
11
8
1
0
2
0
0.42
VA better eye before surgery   
                           20/90 or better
                           20/200–20/100
                           CF-20/250
                           P – HM
12
36
31
2
7
26
20
2
4
10
9
0
1
0
2
0
0.6
VA operated eye postoperative
                           20/90 or better
                           20/200–20/100
                           CF-20/250
                           P – HM
23
36
15
6
14
30
10
1
8
5
5
5
1
1
1
0
0.086
VA better eye postoperatively                
                           20/90 or better
                           20/200–20/100
                           CF-20/250
                           P – HM
30
37
14
0
19
28
8
0
10
7
6
0
1
2
0
0
0.67
Mean improvement VA operated eye, logMAR units 
(SD), p-value†
0.62 (0.71)
0.000
0.71 (0.67)
0.000
0.49 (0.82)
0.0093
0.03 (0.35) 0.28
Mean improvement VA better eye,
logMAR units (SD), p-value†
0.35 (0.60)
0.000
0.38 (0.62)
0.000
0.28 (0.58)
0.047
0.05 (0.09) 0.47
VF-14 before surgery (n = 81) mean(SD) 40.0 (26.7) 30.3 (25.7) 35.0 (27.5) 66.9 (17.8) 0.47
VF-14 postoperatively (n = 81)
mean (SD), p-value†
48.8 (30.2)
0.000
47.4 (28.6)
0.000
49.2 (34.9)
0.024
70.4 (16.7) 0.81
Five-year data 
No of patients with 5-year VF-14 data                35 22 11 2
No with 5-year VA & VF-14 data 30 19 10 1
Mean age 5 years after surgery,
years (SD)
81.1
(13.5)
84.4
(6.1)
82.3
(12.5)
39
(5,7)
0.61
Operated on both eyes after 5 years, %.            78 77 88# 50 0.64
VA operated eye before surgery (n = 30)
                           20/90 or better
                           20/200–20/100
                           CF-20/250
                           P – HM
1
7
17
5
0
5
12
2
1
2
4
3
0
0
1
0
0.76
VA operated eye postop (n = 30) 
                           20/90 or better
                           20/200–20/100
                           CF-20/250
                           P – HM
8
16
5
1
3
12
4
0
5
3
1
1
0
1
0
0
0.39
VA operated eye 5 years after surgery (n = 30) 
                           20/90 or better
                           20/200–20/100
                           CF-20/250
                           P – HM
                           p-value§
2
11
18
4
0.000
0
8
11
0
0.026
1
3
2
4
0.003
1
0
0
0
0.51
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ability with little change 5 years after surgery. M-patients 
compared with G-patients had a worse outcome when read-
ing ability was assessed with a signiﬁ  cant decrease in reading 
score 5 years postoperatively (p = 0.045, Table 4).
The reading score 5 years after surgery showed a strong 
statistically significant correlation with the VA of the 
better seeing eye, both for M-patients as well as G- patients 
(rS = 0.76 and rS = 0.9, respectively, p-values 0.000).
Discussion
The present study provides an evaluation of long-time 
outcome in a geographically deﬁ  ned cohort of low-vision 
Table 1 Continued
Diagnosis
All patients M-patients G-patients RP-patients p-value*
VA better eye bef surg (n = 30)
                           20/90 or better
                           20/200–20/100
                           CF-20/250
                           P – HM
3
17
9
1
2
11
5
1
1
5
4
0
0
1
0
0
0.32
VA better eye postop (n = 30)
                           20/90 or better
                           20/200–20/100
                           CF-20/250
                           P – HM
10
16
4
0
5
12
2
0
5
3
2
0
0
1
0
0
0.92
VA better eye 5 years after surg (n = 30)
                          20/90 or better
                          20/200–20/100
                          CF-20/250
                          P – HM
                          p-value§
10
7
12
1
0.23
5
5
9
0
0.18
5
2
2
1
0.8
0
0
1
0
0.21
Mean VF-14 before surg (n = 35) 37.4 (27.3) 35.4 (28.6) 34.2 (21.9) 76.7 (8.3) 0.99
Mean VF-14 postoperat (n = 35) 53.7 (26.2) 51.7 (24.9) 53.1 (29.8) 79.1 (10.3) 0.86
Mean VF-14 5 years after surg  (n = 35)                    
p-value§
46.6 (31.7)
0.026
40.2 (27.7)
0.004
52.6 (37.6)
0.93
83.0 (8.0) 0.34
Notes: *p-values refer to M-patients versus G-patients (t- tests and Mann-Whitney U-tests); †p-values refer to change postoperatively versus before surgery, (t- tests and 
Mann-Whitney U-tests); §p-values refer to change 5-years after surgery versus postoperatively. (t- tests and Mann-Whitney U-tests); #Two patients with no light perception 
on their fellow eyes were excluded; Values in boldface are statistically signiﬁ  cant (p < 0.05).
Abbreviations: M-patients, maculopathy patients; G-patients, glaucoma patients; RP-patients, retinitis pigmentosa patients; LogMAR, logarithm of the minimum angle of 
resolution;   VA, visual acuity;   VF-14, visual function questionnaire; CF, counting ﬁ  ngers; HM, hand movements; P, light perception.
Table 2 Distribution of change in VA for the operated eye and the better-seeing eye 5 years after surgery versus postoperatively, for 
the Maculopathy patients (M-patients), Glaucoma patients (G-patients), and the retinitis pigmentosa patients (RP-patients) 
Change in VA operated eye   All patients  M-patients  G-patients  RP-patients  p-value
5 years after surgery, no (%)  (n = 30)  (n = 19)  (n = 10)  (n = 1)
Unchanged or better, no (%)  7 (23)  7 (37)  0  0 
0.01–0,3 decline logMAR units  3 (10)  1 (5)  2 (20)  0 
0.31–0.5 decline logMAR units  9 (30)  4 (21)  5 (50)  0 
0.51–0.7 decline logMAR units  7 (23)  6 (32)  0  1 
0.7 decline logMAR units  4 (14)  1 (5)  3 (30)  0  p = 0.33*
Change in VA better seeing eye
5 years after surg, no (%)
Unchanged or better, no (%)  12 (40)  8 (42)  4 (40)  0 
0.01–0,3 decline logMAR units  9 (30)  4 (21)  5 (50)  0 
0.31–0.5 decline logMAR units  5 (17)  4 (21)  0  1 
0.51–0.7 decline logMAR units  3 (10)  3 (16)  0  0 
0.7 decline logMAR units  1 (3)  0  1 (10)  0  p = 0.40*
Notes: *The p-value refers to the difference between M- and G-group (Mann-Whitney U-test).
Abbreviations: VA, best corrected visual acuity; logMAR, logarithm of the minimum angle of resolution.Clinical Ophthalmology 2008:2(1) 192
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patients who had cataract surgery. Our results suggest a 
favorable functional outcome for most low-vision patients, 
with 57% of the patients having unchanged or better VF-14 
score compared with before surgery, and 37% compared 
with postoperatively.
Glaucoma patients were found to have a more stable 
outcome with no signiﬁ  cant change in VF-14 score (Table 1). 
The reason for this might be that the surgical procedure in 
itself generally lowers the intraocular pressure with approxi-
mately 1–3 mmHg, (Hayashi et al 2000, 2001; Mathalone 
et al 2005) and increased efﬁ  ciency of modern pressure-
lowering eye drops.
There was one patient in the G-group with severely dam-
aged visual function caused by a tumor of the hypophysis. 
The G-group was therefore analyzed after excluding this 
patient to ensure that the patient, with perhaps less risk 
for progressive disease than the glaucoma patients, did not 
“confound” the 5-year outcome. The results for the G-group 
did not change by excluding this patient.
It is not surprising that M-patients had a signiﬁ  cantly 
worse 5-year outcome than G-patients when reading abil-
ity was assessed (Table 4).The disease process of AMD 
leads to loss of central vision which causes difﬁ  culties for 
those affected, particularly in reading and other near vision 
activities (Berdeaux et al 2005). Regarding the total low 
vision patient group the subjective reading ability was better 
5 years after surgery compared with before surgery.
The diagnostic groups and the relations between them are 
similar to previous research (Hirvelä and Laatikainen 1995; 
Mönestam and Wachtmeister 1997). As expected macular 
degeneration was the leading cause of low vision.
In outcome studies the VA-result is often associated 
with the subjective visual function assessed by a ques-
tionnaire. In these cases it is essential to assess the VA 
of the patients’ better-seeing eye, as the subjective visual 
function has been shown to depend more on the vision of 
the better eye than the worse eye (Steinberg et al 1994a; 
Mönestam and Wachtmeister 2004). In studies assessing 
cataract surgery outcome one must take account of the fact 
that the patient before surgery, in most instances, has two 
eyes with varying degree of cataract, or that the fellow 
eye might already has had surgery. In long-time studies 
of cataract surgery outcome it is common that the patients 
have second eye surgery during the follow-up period. It 
is important to take account of this when presenting the 
results.
Table 3 Distribution of change in VF-14, 5 years after surgery versus before surgery and postoperatively, respectively
Change in VF-14 score 5 years after   All patients  M-patients  G-patients  RP-patients  p-value
surgery versus before surgery, no (%)  (n = 35)  (n = 22)  (n = 11)  (n = 2) 
Unchanged or better; no (%)  20 (57)  11 (50)  8 (73)  1 (50) 
Worsening of VF-14 score 10  8 (23)  6 (27)  1 (9)  1 (50) 
Worsening of VF-14 score 10–20   5 (14)  3 (14)  2 (18)  0 
Worsening of VF-14 score 20   2 (6)  2 (9)  0  0   0.30*
Change in VF-14 score 5 years after
surgery versus postoperatively, no (%)
VF-14 unchanged or better  13 (37)  5 (23)  6 (55)  2 (100) 
Worsening of VF-14 score 10   7 (20)  6 (27)  1 (9)   
Worsening of VF-14 score 10–20   7 (20)  6 (27)  1 (9)   
Worsening of VF-14 score 20  8 (23)  5 (23)  3 (27)    0.36*
Notes: *The p-values refer to the difference between M- and G-group (Mann-Whitney U-test).
Abbreviations: M-patients, maculopathy patients; G-patients, glaucoma patients; RP-patients, retinitis pigmentosa patients;   VF-14, visual function questionnaire total score.
Table 4 The median subjective reading ability score before surgery, postoperatively, and 5 years after surgery for the patient-groups
Median score   All patients  M-group  G-group  RP-group
(interquartile range)  (n = 35)  (n = 22)  (n = 11)  (n = 2)
Before surgery  2 (6)  2 (5.4)  2 (6)  11 (2)
Postoperatively   5 (7)  5 (6.4)  7 (7)  9.5 (1)
5 years after surgery   3 (7)  1 (5.5)  6 (9)  10 (0)
p-value* 0.14  0.045  0.83 
Notes: *refers to change in reading score 5 years after surgery versus postoperatively (paired Wilcoxon signed rank test).
Abbreviations: M-patients, maculopathy patients, G-patients; glaucoma patients; RP-patients, retinitis pigmentosa patients.Clinical Ophthalmology 2008:2(1) 193
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Five years after surgery the VA of the operated eye had 
deteriorated signiﬁ  cantly but the VAs of the patients’ better-
seeing eyes were not signiﬁ  cantly worse (Table I).
VA of the operated eye was unchanged or better in 37% 
of the M-patients (Table 2). The 5-year change in VA for 
the operated eye is generally variable with a proportion of 
patients with unchanged or only minor deterioration and others 
who have worsened substantially. There was no association 
between age, gender, diagnosis, and degree of deterioration 
which supports the assumption that the severity of the disease-
process for each individual patient might be the most important 
factor affecting the long-time results for the operated eye.
No general conclusions regarding the long-time outcome 
of RP-patients can be made because of the small patient-
group. The patients analyzed in this study had a favorable 
outcome. Long-time studies in this patient group are clearly 
warranted because these patients often have cataract surgery 
at a younger age and have a longer life-span post-surgery 
(Jackson et al 2001).
The strength of the study is that it is population-based 
and prospective, with few dropouts from causes other than 
death and dementia.
Limitations of the study are that the surviving patients 
are relatively few because the mean age of the patients was 
80 years at the time of surgery. Studies assessing any long-
time outcome, 5 years or more, of low vision patients will 
have a large percentage of dropouts, in consistence with 
common knowledge that increasing age is an independent 
predictor of low vision (Buch et al 2001).
The severity of macular degeneration was neither checked 
nor graded before surgery or postoperatively. Reported visual 
function has been found to be signiﬁ  cantly associated with 
the clinical severity of age-related maculopathy (Mangione 
et al 1999). Our study patients were low vision patients as 
a result of their disease and had a substantial age-related 
macular degeneration before surgery.
Other objective dimensions of visual function such as 
contrast sensitivity, glare disability, etc. were not analyzed 
in this study. We focused on the most common test of visual 
function ie distance VA and correlated the ﬁ  ndings to the 
subjective statements of the patients. It is possible that, for 
instance, contrast sensitivity testing would add information 
especially concerning the dissatisﬁ  ed group.
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